CTXR
Citius Pharmaceuticals, Inc.
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The accompanying unaudited consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. We incurred a net loss of $37,503,635 for the six months ended March 31, 2026. The Company experienced negative cash flows from operations of $14,308,843 for the six months ended March 31, 2026. At March 31, 2026, the Company had $4,590,174 in cash and a negative working capital of approximately $23.3 million.”View the 10-Q filed May 15, 2026
Company with tickers: CTXR
CIK
1506251
CUSIP
17322U306
Shares Outstanding
27,452,570
Website
https://www.citiuspharma.com
Investor Relations
https://www.citiuspharma.com/investors/
13F Activity (30d)
3 filings
2 filers
Press releases and events scraped from the company's investor relations website. News and event listings link back to the original source.